ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Obit: Former Roswell Park Director Gerald Murphy, 65, In Tel Aviv.

January 28, 2000

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

In Brief: Job Discrimination Survey Report Not Ready Until Next Month; Saccharin Date Extended

September 17, 1977